Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Data mining for signals in spontaneous reporting databases: proceed with caution.

Wendy P Stephenson1, Manfred Hauben

  • 1Wendy Stephenson & Associates LLC, Maple Glen, PA 19002, USA. wendypstephenson@aol.com

Pharmacoepidemiology and Drug Safety
|October 5, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.

Drug safety·2026
Same author

Verbal Expressions of Probability in Pharmacovigilance: Most Likely Too Ambiguous.

Clinical therapeutics·2026
Same author

A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.

Drug safety·2026
Same author

Perspective on Better Access to Data and Data Integration in Pharmacovigilance: Information from a Focus Group.

Drug safety·2026
Same author

How LLMs can advance safety case intake-points to consider and insights from a proof of concept.

Therapeutic advances in drug safety·2025
Same author

Current Approaches in Postapproval Vaccine Safety Studies Using Real-World Data: A Systematic Review of Published Literature.

Clinical therapeutics·2024
Same journal

Effectiveness of Metformin in Preventing Colorectal Cancer Among Japanese Patients With Type 2 Diabetes: A Target Trial Emulation.

Pharmacoepidemiology and drug safety·2026
Same journal

Trends in Pharmacist-Prescribed Dispensing Records of HIV Pre-Exposure (2020-2025) and Post-Exposure Prophylaxis (2020-2024) in Brazil: A Time Series Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

French Consumption of Methylphenidate in Primary Care From 2016 to 2023, Impact of Prescribing Policy Changes-A Time-Series Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

Uptake and Use of Biologic Therapies in Paediatric Immune-Mediated Inflammatory Diseases: An Australian Population-Based Study.

Pharmacoepidemiology and drug safety·2026
Same journal

Comparative Effectiveness of Oral Fluoropyrimidines Versus FOLFOX as Adjuvant Therapy for Stage III Colon Cancer: A Retrospective Cohort Study Using Overlap-Weighted Restricted Mean Survival Time Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

Association Between EGFR-TKI-Associated Skin Rash and Recorded Mortality in Non-Small Cell Lung Cancer: A Real-World Analysis Accounting for Immortal Time Bias.

Pharmacoepidemiology and drug safety·2026
See all related articles

Before using data mining in pharmacovigilance, understand its limitations and predictive value. Further research is needed to define its true benefit alongside traditional drug safety methods.

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Data Mining in Healthcare
  • Post-Marketing Surveillance

Background:

  • Traditional pharmacovigilance relies on spontaneous reporting systems.
  • Emerging data mining tools offer new approaches to signal detection.
  • The integration of these tools into routine surveillance requires careful consideration.

Purpose of the Study:

  • To offer commentary and cautionary advice on implementing data mining in pharmacovigilance.
  • To encourage research into the predictive and incremental value of data mining.
  • To guide the effective use of data mining alongside established methods.

Main Methods:

  • Review of current data mining methodologies used in pharmacovigilance.
  • Analysis of limitations associated with these methodologies.

Related Experiment Videos

  • Examination of caveats in utilizing spontaneous reporting databases.

    • Main Results:

    • Current data mining techniques have inherent limitations.
    • Over-reliance on data mining results without critical evaluation is cautioned.
    • Spontaneous reporting databases require careful interpretation when used with data mining.

    Conclusions:

    • Further research is essential to clarify the limitations of quantitative data mining approaches.
    • The incremental value of data mining compared to traditional pharmacovigilance methods needs further definition.
    • A balanced approach, considering both new tools and traditional methods, is crucial for robust drug safety.